MR Imaging–Based Correction for Partial Volume Effect Improves Detectability of Intractable Epileptogenic Foci on Iodine 123 Iomazenil Brain SPECT Images: An Extended Study with a Larger Sample Size

References

1. 1.↵
   1. Sata Y,
   2. Matsuda K,
   3. Mihara T,
   4. et al

   . Quantitative analysis of benzodiazepine receptor in temporal lobe epilepsy: [(125)I]iomazenil autoradiographic study of surgically resected specimens. Epilepsia 2002; 43: 1039– 48

   CrossRefPubMed
2. 2.↵
   1. Beer HF,
   2. Blauenstein PA,
   3. Hasler PH,
   4. et al

   . In vitro and in vivo evaluation of iodine-123-Ro 16–0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 1990; 31: 1007– 14

   Abstract/FREE Full Text
3. 3.↵
   1. Morimoto K,
   2. Watanabe T,
   3. Ninomiya T,
   4. et al

   . Quantitative evaluation of central-type benzodiazepine receptors with [(125)I]Iomazenil in experimental epileptogenesis: II. The rat cortical dysplasia model. Epilepsy Res 2004; 61: 113– 18

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Hoffman EJ,
   2. Huang SC,
   3. Phelps ME

   . Quantitation in positron emission computed tomography. 1. Effect of object size. J Comput Assist Tomogr 1979; 3: 299– 308

   PubMedWeb of Science
5. 5.↵
   1. Kato H,
   2. Shimosegawa E,
   3. Oku N,
   4. et al

   . MRI-based correction for partial-volume effect improves detectability of intractable epileptogenic foci on 123I-iomazenil brain SPECT images. J Nucl Med 2008; 49: 383– 89

   Abstract/FREE Full Text
6. 6.↵
   1. Engel J Jr.

   1. Engel J Jr,
   2. Van Ness P,
   3. Rasmussen TB,
   4. et al

   . Outcome with respect to epileptic seizures. In: Engel J Jr. , ed. Surgical Treatment of the Epilepsies. New York: Raven Press; 1993: 609– 21
7. 7.↵
   1. Chang LT

   . A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; 25: 638– 43

   CrossRefWeb of Science
8. 8.↵
   1. Ashburner J,
   2. Friston KJ

   . Unified segmentation. Neuroimage 2005; 26: 839– 51

   CrossRefPubMedWeb of Science
9. 9.
   1. Good CD,
   2. Johnsrude IS,
   3. Ashburner J,
   4. et al

   . A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 21– 36

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Ashburner J,
    2. Friston KJ

    . Voxel-based morphometry: the methods. Neuroimage 2000; 11: 805– 21

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Bencherif B,
    2. Stumpf MJ,
    3. Links JM,
    4. et al

    . Application of MRI-based partial-volume correction to the analysis of PET images of mu-opioid receptors using statistical parametric mapping. J Nucl Med 2004; 45: 402– 08

    Abstract/FREE Full Text
12. 12.↵
    1. Matsuda H,
    2. Ohnishi T,
    3. Asada T,
    4. et al

    . Correction for partial-volume effects on brain perfusion SPECT in healthy men. J Nucl Med 2003; 44: 1243– 52

    Abstract/FREE Full Text
13. 13.↵
    1. Ibanez V,
    2. Pietrini P,
    3. Alexander GE,
    4. et al

    . Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 1998; 50: 1585– 93

    Abstract/FREE Full Text
14. 14.↵
    1. Jenkinson M,
    2. Smith S

    . A global optimisation method for robust affine registration of brain images. Med Image Anal 2001; 5: 143– 56

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Zhou FW,
    2. Roper SN

    . Densities of glutamatergic and GABAergic presynaptic terminals are altered in experimental cortical dysplasia. Epilepsia 2010; 51: 1468– 76

    CrossRefPubMedWeb of Science
16. 16.↵
    1. White R,
    2. Hua Y,
    3. Scheithauer B,
    4. et al

    . Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann Neurol 2001; 49: 67– 78

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Bonilha L,
    2. Montenegro MA,
    3. Rorden C,
    4. et al

    . Voxel-based morphometry reveals excess gray matter concentration in patients with focal cortical dysplasia. Epilepsia 2006; 47: 908– 15

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Woermann FG,
    2. Free SL,
    3. Koepp MJ,
    4. et al

    . Voxel-by-voxel comparison of automatically segmented cerebral gray matter: a rater-independent comparison of structural MRI in patients with epilepsy. Neuroimage 1999; 10: 373– 84

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Aronica E,
    2. Boer K,
    3. Becker A,
    4. et al

    . Gene expression profile analysis of epilepsy-associated gangliogliomas. Neuroscience 2008; 151: 272– 92

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Richardson MP,
    2. Hammers A,
    3. Brooks DJ,
    4. et al

    . Benzodiazepine-GABA(A) receptor binding is very low in dysembryoplastic neuroepithelial tumor: a PET study. Epilepsia 2001; 42: 1327– 34

    CrossRefPubMed
21. 21.↵
    1. Haglund MM,
    2. Berger MS,
    3. Kunkel DD,
    4. et al

    . Changes in gamma-aminobutyric acid and somatostatin in epileptic cortex associated with low-grade gliomas. J Neurosurg 1992; 77: 209– 16

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Keller SS,
    2. Wilke M,
    3. Wieshmann UC,
    4. et al

    . Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy. Neuroimage 2004; 23: 860– 68

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Bernasconi N,
    2. Duchesne S,
    3. Janke A,
    4. et al

    . Whole-brain voxel-based statistical analysis of gray matter and white matter in temporal lobe epilepsy. Neuroimage 2004; 23: 717– 23

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Quarantelli M,
    2. Berkouk K,
    3. Prinster A,
    4. et al

    . Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med 2004; 45: 192– 201

    Abstract/FREE Full Text
25. 25.↵
    1. Meltzer CC,
    2. Kinahan PE,
    3. Greer PJ,
    4. et al

    . Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med 1999; 40: 2053– 65

    Abstract/FREE Full Text
26. 26.↵
    1. Rousset OG,
    2. Ma Y,
    3. Evans AC

    . Correction for partial volume effects in PET: principle and validation. J Nucl Med 1998; 39: 904– 11

    Abstract/FREE Full Text
27. 27.↵
    1. Soret M,
    2. Bacharach SL,
    3. Buvat I

    . Partial-volume effect in PET tumor imaging. J Nucl Med 2007; 48: 932– 45

    Abstract/FREE Full Text